References
- Adamska M, Lutomski J. (1971). C-flavonoid glycosides in the seeds of Trigonella foenum-graecum. Planta Med 20:224–9
- Bagchi D, Sreejayan N, eds. (2012). Nutritional and therapeutic interventions for diabetes and metabolic syndrome. Amsterdam: Academic Press
- Bordia A, Verma SK, Srivastava KC. (1997). Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenum-graceum Linn.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 56:379–84
- Brunetti A, Chiefari E, Foti D. (2014). Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes 5:128–40
- Clive D, McCuen R, Spector JF, et al. (1983). Specific gene mutations in L5178Y cells in culture. Mutat Res 115:225–51
- Elujoba AA, Hardman R. (1987). Saponin-hydrolyzing enzymes from fenugreek seed. Fitoterapia 58:197–9
- FDA. (1987). Good laboratory practices (GLP) for non-clinical laboratory studies. In: Services. D.O.H.a.H. Washington, DC: US Food and Drug Administration, 297–310
- Gupta RK, Jain DC, Thakur RS. (1986). Minor steroidal sapogenins from fenugreek seeds, Trigonella foenum-graecum. J Nat Prod 49:1153
- Madar Z, Abel R, Samish S, Arad J. (1988). Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr 42:51–4
- Maron DM, Ames BN. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215
- National Research Council. (2011). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press, 1–220
- Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. (2014). Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutr J 13:1–11
- Nour AAM, Magboul BI. (1986). Chemical and amino acid composition of fenugreek grown in Sudan. Food Chem 22:1–5
- OECD. (1998). Principles of good laboratory practice. Paris: Committee, C.G.a.M. Organization for Economic Co-operation and Development
- Paneni F, Costantino S, Cosentino F. (2014). Insulin resistance, diabetes, and cardiovascular research. Curr Atheroscler Rep 16:419–31
- Prasanna M. (2000). Hypolipidemic effect of fenugreek: a clinical study. Ind J Pharmacol 32:34–6
- Sauvaire Y, Baccou JC. (1978). Extraction of diosgenin, (25R)-spirost-5-ene-3-beta-ol; problems of the hydrolysis of the saponins. Lloydia 41:247–56
- Sauvaire Y, Ribes G, Baccou JC, Loubatieeres-Mariani MM. (1991). Implication of steroid saponins and sapogenins in the hypocholesterolemic effect of fenugreek. Lipids 26:191–7
- Sharma RD, Raghuram TC, Rao NS. (1990). Effect of fenugreek seeds on blood glucose and serum lipids in type 1 diabetes. Eur J Clin Nutr 44:301–6
- Sharma RD, Raghuram TC, Dayasagar Rao V. (1991). Hypolipidaemic effect of fenugreek seeds. A clinical study. Phytotherapy Res 5:145–7
- Sharma RD, Sarkar A, Hazra DK, et al. (1996). Hypolipidaemic effects of fenugreek seeds: a chronic study in non-insulin dependent diabetic patients. Phytotherapy Res 10:332–4
- Singhal PC, Gupta RK, Joshi LD. (1982). Hypocholesterolemic effect of Trigonella foenum-graecum (Methi). Curr Sci 51:136–7
- Stark A, Madar Z. (1993). The effect of an ethanol extract derived from fenugreek (Trigonella foenum traecum) on bile acid absorption and cholesterol levels in rats. Br J Nutr 69:277–87
- Valette G, Sauvaire Y, Baccou JC, Ribes G. (1984). Hypocholesterolaemic effect of fenugreek seeds in dogs. Atherosclerosis 50:105–11
- Yadav UC, Baquer NZ. (2014). Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol 52:243–54